NFKB1 and carcinoma: Suitable anti-inflammatory dietary components, which inhibit NF-kB initiation and inflammation-related inflammatory processes, may reduce the signs of carcinoma as disruption of inflammatory pathways, which leads to elevated concentrations of the pro-inflammatory cytokines, like IL-6 as well as NF-kB is linked to different malignancies [124].